These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38636615)

  • 1. Molecular and cellular consequences of mevalonate kinase deficiency.
    Politiek FA; Turkenburg M; Henneman L; Ofman R; Waterham HR
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167177. PubMed ID: 38636615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mevalonate kinase-deficient THP-1 cells show a disease-characteristic pro-inflammatory phenotype.
    Politiek FA; Turkenburg M; Ofman R; Waterham HR
    Front Immunol; 2024; 15():1379220. PubMed ID: 38550596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of FDA-approved drugs that increase mevalonate kinase in hyper IgD syndrome.
    Politiek FA; Turkenburg M; Koster J; Ofman R; Waterham HR
    J Inherit Metab Dis; 2024 Mar; 47(2):302-316. PubMed ID: 38131282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency.
    Munoz MA; Jurczyluk J; Simon A; Hissaria P; Arts RJW; Coman D; Boros C; Mehr S; Rogers MJ
    Front Immunol; 2019; 10():1900. PubMed ID: 31474985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency.
    Mandey SH; Schneiders MS; Koster J; Waterham HR
    Hum Mutat; 2006 Aug; 27(8):796-802. PubMed ID: 16835861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency.
    Politiek FA; Waterham HR
    Front Immunol; 2021; 12():724991. PubMed ID: 34539662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency.
    Henneman L; Schneiders MS; Turkenburg M; Waterham HR
    J Inherit Metab Dis; 2010 Oct; 33(5):625-32. PubMed ID: 20814828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of Prenylated Proteins, Autophagy Impairment and Apoptosis in SH-SY5Y Neuronal Cell Model of Mevalonate Kinase Deficiency.
    Tricarico PM; Romeo A; Gratton R; Crovella S; Celsi F
    Cell Physiol Biochem; 2017; 41(4):1649-1660. PubMed ID: 28359055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel missense mutation in MVK associated with MK deficiency and dyserythropoietic anemia.
    Samkari A; Borzutzky A; Fermo E; Treaba DO; Dedeoglu F; Altura RA
    Pediatrics; 2010 Apr; 125(4):e964-8. PubMed ID: 20194276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory deficiency in yeast mevalonate kinase deficient may explain MKD-associate metabolic disorder in humans.
    Santos MMS; Elsztein C; De Souza RB; Paiva SSL; Silva JA; Crovella S; De Morais MA
    Curr Genet; 2018 Aug; 64(4):871-881. PubMed ID: 29374778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of isoprenoid/cholesterol biosynthesis in cells from mevalonate kinase-deficient patients.
    Houten SM; Schneiders MS; Wanders RJ; Waterham HR
    J Biol Chem; 2003 Feb; 278(8):5736-43. PubMed ID: 12477733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of mevalonate-5-phosphate using UPLC-MS/MS for determination of mevalonate kinase activity.
    Reitzle L; Maier B; Stojanov S; Teupser D; Muntau AC; Vogeser M; Gersting SW
    Clin Biochem; 2015 Aug; 48(12):781-7. PubMed ID: 25982894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome.
    Houten SM; Frenkel J; Rijkers GT; Wanders RJ; Kuis W; Waterham HR
    Hum Mol Genet; 2002 Dec; 11(25):3115-24. PubMed ID: 12444096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mevalonate kinase deficiency leads to decreased prenylation of Rab GTPases.
    Jurczyluk J; Munoz MA; Skinner OP; Chai RC; Ali N; Palendira U; Quinn JM; Preston A; Tangye SG; Brown AJ; Argent E; Ziegler JB; Mehr S; Rogers MJ
    Immunol Cell Biol; 2016 Nov; 94(10):994-999. PubMed ID: 27377765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incomplete mitophagy in the mevalonate kinase-deficient Saccharomyces cerevisiae and its relation to the MKD-related autoinflammatory disease in humans.
    Santos MMS; Gatica D; de Azêvedo Silva J; Crovella S; Klionsky DJ; De Morais MA
    Biochim Biophys Acta Mol Basis Dis; 2021 Apr; 1867(4):166053. PubMed ID: 33385519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasculitis in a patient with mevalonate kinase deficiency (MKD): a case report.
    Omoyinmi E; Rowczenio D; Sebire N; Brogan PA; Eleftheriou D
    Pediatr Rheumatol Online J; 2021 Nov; 19(1):161. PubMed ID: 34809655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific increase in caspase-1 activity and secretion of IL-1 family cytokines: a putative link between mevalonate kinase deficiency and inflammation.
    Normand S; Massonnet B; Delwail A; Favot L; Cuisset L; Grateau G; Morel F; Silvain C; Lecron JC
    Eur Cytokine Netw; 2009 Sep; 20(3):101-7. PubMed ID: 19825518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possibly new autoinflammatory disease due to compound heterozygous phosphomevalonate kinase gene mutation.
    Yıldız Ç; Gezgin Yıldırım D; Inci A; Tümer L; Cengiz Ergin FB; Sunar Yayla ENS; Esmeray Şenol P; Karaçayır N; Eğritaş Gürkan Ö; Okur I; Ezgü FS; Bakkaloğlu SA
    Joint Bone Spine; 2023 Jan; 90(1):105490. PubMed ID: 36410683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unprenylated RhoA contributes to IL-1β hypersecretion in mevalonate kinase deficiency model through stimulation of Rac1 activity.
    van der Burgh R; Pervolaraki K; Turkenburg M; Waterham HR; Frenkel J; Boes M
    J Biol Chem; 2014 Oct; 289(40):27757-65. PubMed ID: 25107911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current advances in the understanding and treatment of mevalonate kinase deficiency.
    Esposito S; Ascolese B; Senatore L; Bosis S; Verrecchia E; Cantarini L; Rigante D
    Int J Immunopathol Pharmacol; 2014; 27(4):491-8. PubMed ID: 25572728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.